[Breaking] Kolon Life Science Executives Acquitted of 'Invossa Ingredient Manipulation' Charges
![[Breaking] Kolon Life Science Executives Acquitted of 'Invossa Ingredient Manipulation' Charges](http://www.asiae.co.kr/news/img_view.htm?img=2020120409454047289_1607042740.png)
[Asia Economy Reporter Lim Juhyung] Executives of Kolon Life Science were indicted on charges of manipulating the components of the osteoarthritis gene therapy drug Invossa KJ (hereafter Invossa) and submitting false documents to authorities, but they were acquitted in the first trial.
The Criminal Division 25-3 of the Seoul Central District Court (Presiding Judges Kwon Seongsu, Kim Seonhee, and Im Jeongyeop) on the 19th acquitted Kolon Life Science director Cho and executive director Kim of charges including obstruction of official duties by deception, fraud under the Act on the Aggravated Punishment of Specific Economic Crimes, and violation of the Subsidy Act.
Hot Picks Today
"You Might Regret Not Buying Now"... Overseas Retail Investors Stirred by News of Record-Breaking Monster Stocks' IPOs
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Mistaken for the Flu, Left Untreated... Death Toll Surges as WHO Declares Emergency (Comprehensive)
- Chinese Navy Launches Aircraft Carrier Fleet Drills in Western Pacific: "Conducting Long-Range Flights and Live-Fire Exercises"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
However, Cho was found guilty only of bribery for giving approximately 2 million KRW to a Ministry of Food and Drug Safety official along with a request for convenience during the development process of Invossa, and was fined 5 million KRW.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
